Isaac Kinde: Finding cancer via altered genes
Baltimore biotech star aims to detect cancer mutations early
DETECTION Isaac Kinde, 31, is the chief scientific officer of PapGene, Inc. The company’s technologies can identify mutations commonly associated with cancer.
Courtesy of I. Kinde
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
